Thorac Cardiovasc Surg 2009; 57(4): 196-201
DOI: 10.1055/s-0029-1185394
Original Cardiovascular

© Georg Thieme Verlag KG Stuttgart · New York

Bovine Jugular Veins in the Pulmonary Position in Adults – 5 Years' Experience with 64 Implantations

D. Boethig1 , M. Westhoff-Bleck2 , H. Hecker3 , M. Ono4 , A. Goerler4 , S. Sarikouch4 , T. Breymann4
  • 1Pediatric Cardiology and Intensive Care Medicine, Hannover Medical School, Hannover, Germany
  • 2Cardiology, Hannover Medical School, Hannover, Germany
  • 3Biometry, Hannover Medical School, Hannover, Germany
  • 4Cardiac, Thoracic, Transplant and Vascular Surgery, Hannover Medical School, Hannover, Germany
Further Information

Publication History

received October 14, 2008

Publication Date:
20 May 2009 (online)

Abstract

Objective: The midterm durability of bovine jugular veins (BJV) in children is comparable to that of homografts. We present the results of 64 bovine jugular vein implantations in adults in a pulmonary position. Methods: Between August 2003 and July 2008, 60 patients (aged 18 to 65 years) received 64 BJVs. 97 % of them had had previous reconstructions of the right ventricular outflow tract. Diagnoses for treatment included tetralogy of Fallot (n = 49 patients), other congenital malformations (n = 14), and Ross operation (n = 1). Four bovine jugular veins had a diameter of 20 mm, the others had a diameter of 22 mm. Results: Survival after 5 years was 98.4 ± 1.6 %. Freedom from endocarditis: 84.8 ± 8.0 % (4 patients required explantation for endocarditis); freedom from explantation for structural valve degeneration: 96.2 ± 2.6 % (2 patients required explantation); freedom from intervention: 93.2 ± 2.8 % (3 patients required intervention); moderate insufficiency: 62.9 ± 15.1 % (8 patients); gradient ≥ 50 mmHg: 79.6 ± 7.4 % (7 patients); degeneration: 56.4 ± 12.9 % (11); any adverse event: 43.1 ± 12.8 % (15 patients); calcification or aneurysmal dilatation: 100 %. At any postoperative interval, more than 75 % of the BJVs had neither been explanted nor were they degenerated. Conclusion: The BJV might be a promising alternative to homografts, also in adults. Strict antibiotic prophylaxis is mandatory. A prospective randomized multicenter comparison of homografts and BJVs would help to identify the preferable conduit.

References

  • 1 Carrel T, Berdat P, Pavlovic M, Pfammatter J P. The bovine jugular vein: a totally integrated valved conduit to repair the right ventricular outflow.  J Heart Valve Dis. 2002;  11 552-556
  • 2 Corno A F, Hurni M, Griffin H, Galal O M, Payot M, Sekarski N. et al . Bovine jugular vein as right ventricle-to-pulmonary artery valved conduit.  J Heart Valve Dis. 2002;  11 242-247
  • 3 Breymann T, Thies W R, Boethig D, Goerg R, Blanz U, Koerfer R. Bovine valved venous xenografts for RVOT reconstruction: results after 71 implantations.  Eur J Card Surg. 2002;  21 703-710
  • 4 Sierra J, Christenson J T, Lahlaidi N H, Beghetti M, Kalangos A. Right ventricular outflow tract reconstruction: what conduit to use? Homograft or Contegra?.  Ann Thorac Surg. 2007;  84 606-610
  • 5 Hickey E J, McCrindle B W, Blackstone E H, Yeh Jr T, Pigula F, Clarke D. et al . Jugular venous valved conduit (Contegra) matches allograft performance in infant truncus arteriosus repair.  Eur J Cardiothorac Surg. 2008;  33 890-898
  • 6 Corno A F, Qanadli S D, Sekarski N, Artemisia S, Hurni M, Tozzi P. et al . Bovine valved xenograft in pulmonary position: medium-term follow-up with excellent hemodynamics and freedom from calcification.  Ann Thorac Surg. 2004;  78 1382-1388
  • 7 Shebani S O, McGuirk S, Baghai M, Stickley J, De Giovanni J V, Bu'Lock F A. et al . Right ventricular outflow tract reconstruction using Contegra valved conduit: natural history and conduit performance under pressure.  Eur J Card Surg. 2006;  29 397-405
  • 8 Chatzis A C, Giannopoulos N M, Bobos D, Kirvassilis G B, Rammos S, Sarris G E. New xenograft valved conduit (Contegra) for right ventricular outflow tract reconstruction.  Heart Surg Forum. 2003;  6 396-398
  • 9 Niemantsverdriet M B, Ottenkamp J, Gauvreau K, Del Nido P J, Hazenkamp M G, Jenkins K J. Determinants of right ventricular outflow tract conduit longevity: a multinational analysis.  Congenit Heart Dis. 2008;  3 176-184
  • 10 Capps S B, Elkins R C, Fronk D M. Body surface area as a predictor of aortic and pulmonary valve diameter.  J Thorac Cardiovasc Surg. 2000;  119 975-982
  • 11 Akins C W, Miller D C, Turina M I, Kouchoukos N T, Blackstone E H, Grunkemeier G L. et al . Guidelines for reporting mortality and morbidity after cardiac valve interventions.  J Thorac Cardiovasc Surg. 2008;  135 732-738
  • 12 Boethig D, Thies W R, Hecker H, Breymann T. Mid term course after pediatric right ventricular outflow tract reconstruction: a comparison of homografts, porcine xenografts and Contegras.  Eur J Cardiothorac Surg. 2005;  27 58-66
  • 13 Karamlou T, Blackstone E H, Hawkins J A, Jacobs M L, Kanter K R, Brown J W. et al . Can pulmonary conduit dysfunction and failure be reduced in infants and children less than age 2 years at initial implantation?.  J Thorac Cardiovasc Surg. 2006;  132 829-838
  • 14 Rastan A J, Walther T, Daehnert I, Hambsch J, Mohr F W, Janousek J. et al . Bovine jugular vein conduit for right ventricular outflow tract reconstruction: evaluation of risk factors for mid-term outcome.  Ann Thorac Surg. 2006;  82 1308-1315
  • 15 Boethig D, Goerler H, Westhoff-Bleck M, Ono M, Daiber A, Haverich A. et al . Evaluation of 188 consecutive homografts implanted in pulmonary position after 20 years.  Eur J Cardiothorac Surg. 2007;  32 133-142
  • 16 http://www.eactscongenitaldb.org/db/public-reports.py?fnc=r42name=ecdb6y2005
  • 17 http://www.sts.org/sections/stsnationaldatabase/publications/executive/article.html
  • 18 Carrel T. Bovine valved jugular vein (Contegra) to reconstruct the right ventricular outflow tract.  Expert Rev Med Devices. 2004;  1 11-19
  • 19 Brown J W, Ruzmetov M, Rodefeld M D, Vijay P, Darragh R K. Valved bovine jugular vein conduits for right ventricular outflow tract reconstruction in children: an attractive alternative to pulmonary homograft.  Ann Thorac Surg. 2006;  82 909-916
  • 20 Schoen F J, Mitchell R N, Jonas R A. Pathological considerations in cryopreserved allograft heart valves.  J Heart Valve Dis. 1995;  4 (Suppl. 1) S72-S75
  • 21 Yankah A C, Alexi-Meskhishvili V, Weng Y, Berger F, Lange P, Hetzer R. Performance of aortic and pulmonary homografts in the right ventricular outflow tract in children.  J Heart Valve Dis. 1995;  4 392-395
  • 22 Göber V, Berdat P, Pavlovic M, Pfammatter J P, Carrel T P. Adverse mid-term outcome following RVOT reconstruction using the Contegra valved bovine jugular vein.  Ann Thorac Surg. 2005;  79 625-631
  • 23 Meyns B, Van Garsse L, Boshoff D, Eyskens B, Mertens L, Gewillig M. et al . The Contegra conduit in the right ventricular outflow tract induces supravalvular stenosis.  J Thorac Cardiovasc Surg. 2004;  128 834-840
  • 24 Karamlou T, Blackstone E H, Hawkins J A, Jacobs M L, Kanter K R, Brown J W. et al . Can pulmonary conduit dysfunction and failure be reduced in infants and children less than age 2 years at initial implantation?.  J Thorac Cardiovasc Surg. 2006;  132 829-838
  • 25 Morales D L, Braud B E, Gunter K S, Carberry K E, Arrington K A, Heinle J S. et al . Encouraging results for the Contegra conduit in the problematic right ventricle-to-pulmonary artery connection.  J Thorac Cardiovasc Surg. 2006;  132 665-671
  • 26 Sekarski N, van Meir H, Rijlaarsdam M E, Schoof P H, Koolbergen D R, Hruda J. et al . Right ventricular outflow tract reconstruction with the bovine jugular vein graft: 5 years' experience with 133 patients.  Ann Thorac Surg. 2007;  84 599-605
  • 27 Dave H H, Kadner A, Berger F, Seifert B, Dodge-Khatami A, Béttex D. et al . Early results of the bovine jugular vein graft used for reconstruction of the right ventricular outflow tract.  Ann Thorac Surg. 2005;  79 618-624
  • 28 Raja S G. Contegra conduit: current outcomes and concerns.  Expert Rev Cardiovasc Ther. 2006;  4 721-730
  • 29 Oosterhof T, Meijboom F J, Vliegen H W, Hazekamp M G, Zwinderman A H, Bouma B J. et al . Long-term follow-up of homograft function after pulmonary valve replacement in patients with tetralogy of Fallot.  Eur Heart J. 2006;  27 1478-1484
  • 30 Yacoub M H, Klieverik L M, Melina G, Edwards S E, Sarathchandra P, Bogers A J. et al . An evaluation of the Ross operation in adults.  J Heart Valve Dis. 2006;  15 531-539
  • 31 Cebotari S, Lichtenberg A, Tudorache I, Hilfiker A, Mertsching H, Leyh R. et al . Clinical application of tissue engineered human heart valves using autologous progenitor cells.  Circulation. 2006;  114 (Suppl. 1) I132-I137
  • 32 Haverich A. Cardiac tissue engineering.  Eur J Cardiothorac Surg. 2008;  34 227-228

Dr. Dietmar Boethig

Hannover Medical School
Pediatric Cardiology and Intensive Care Medicine

Carl-Neuberg-Straße 1

30625 Hannover

Germany

Phone: + 49 (0) 511532 94 24

Fax: + 49 (0) 51 15 32 84 19

Email: boethig.dietmar@mh-hannover.de

    >